SRC and neoplasm: Flow cytometry analysis of the BCSC population and tumorsphere growth assay also revealed that downregulation of SRC dramatically reduced the percentage of CD44+/CD24−/low population, and the tumor cell self-renewal ability (Fig. 2K–L and S3B-C).